Early and late IgG of rabbits immunized with herpes virus showed, respectively, 8-fold and 2-fold enhancement of neutralization endpoint in the presence of complement (C). Kinetic curve experiments employing an appropriate amount of virus revealed that both neutralization and sensitization followed firstorder reaction, and each IgG possessed a certain range of concentration where neutralization was negligible while sensitization was marked. Dose responses of neutralization and sensitization velocities demonstrated that the C enhancement of late IgG was about 7-fold and that of early IgG more than 20-fold. These facts suggested that the IgGs contained two different entities of complement-requiring (CRN) and non-requiring neutralizing (N) antibodies at different proportions, only the former being responsible for sensitization. The different CRN: N ratios obtained by the endpoint and kinetic methods may mean either that the two antibodies differ in avidity for the virus or that the number of critical sites per virion for CRN antibody is greater than that for N antibody. In this interpretation, sensitization by CRN antibody as well as neutralization by N antibody is thought to result from attachment of a single antibody molecule to the viral critical site. Alternative explanations, ascribing the mechanism of neutralization to steric hindrance of critical sites or to multiple hit of those sites by antibody, were denied by analyses of the present data.Enhancement of viral neutralization by complement (C) has attracted interest of many investigators, but the mechanism of viral sensitization by antibody for subsequent inactivation by C still remains in the realm of speculation. Explanations ascribing the C action to coverage of a wide area of viral surface (5,12, 17), to aggregation of virus-antibody complexes (23) or to virolysis (1, 17, 24) cannot account for the reason why the C enhancement differs between early and late antibodies of rabbits immunized with herpes simplex virus (HSV) (26). One could presume that IgM antibody might represent complement-requiring neutralizing (CRN) antibody.